MAFLD: What Is It?

Houston Methodist

D. Victor

Round Table: Pre- and Post- Transplant Complications

Rush University Medical Center

C. Aloman, L. Brown, S. Janardhan

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

Liver Fat, Iron, Fibrosis, (and T1): Quantitative MRI in Chronic Liv…

UCSF School of Medicine

M. A. Ohliger

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Long Term Management of Liver Transplant Recipients

UCLA Health

G. Choi

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Current Treatment of Metabolic Dysfunction Associated with Steatotic…

Indiana University School of Medicine Division of Gastroenterology and Hepatology

N. Samala

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

The Evolving Landscape of Non-Alcoholic Fatty Liver Disease (NAFLD) …

Cardiometabolic Health Congress (CMHC)

K. Cusi

Heart and Liver Interactions

Houston Methodist DeBakey Heart and Vascular Center

S. Adeel Ahsan

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

New Therapies in Primary Biliary Cholangitis and Approaches in Autoi…

UCLA Health

S. Iriana

Fatty Liver Disease: When to Refer?

Yale School of Medicine

Rising Burden of Alcohol Use Disorder: Management and Outcomes

Scripps Health

J. Gutierrez